BIOMAT Database Logo BIOMAT Database Logo

[Practical aspects of glucocorticosteroid therapy]. 1984

F J Frey

Alternate-day corticosteroid regimens have been advocated for maintenance therapy of several disorders. The objectives of this dose-spacing regimen are to decrease the undesired side effects of corticosteroids and at the same time to preserve their therapeutic effect. An analysis of the literature reveals that both the desired and the undesired effects of corticosteroids are decreased in alternate-day regimens as compared to daily regimens; whether dose-spacing improves the ratio of desired to undesired effects has not yet been established. Since for pharmacokinetic reasons the total exposure to prednisolone is lower in alternate-day regimens than in daily regimens, there is no reason to convert the daily prednisone regimen into an alternate-day schedule, instead of simply reducing the daily dose, in a patient with a good response to daily prednisone. Chronic maintenance of supraphysiologic levels of glucocorticoids is associated with the development of osteopenia. One mechanism responsible for osteopenia is an increase in bone resorption rates attributable to increased parathyroid hormone secretion secondary to inhibition of intestinal calcium absorption. There is evidence that administration of 25-hydroxyvitamin D and calcium may abrogate glucocorticosteroid-induced inhibition of intestinal calcium absorption and improve glucocorticoid-induced osteopenia. This evidence is discussed.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F J Frey
[Current aspects of nasal glucocorticosteroid therapy].
July 2000, HNO,
F J Frey
Lithium therapy: practical aspects.
May 1976, Diseases of the nervous system,
F J Frey
Practical aspects of anticoagulant therapy.
August 1950, Wisconsin medical journal,
F J Frey
Practical aspects of anticonvulsant therapy.
June 1979, The American journal of nursing,
F J Frey
Practical aspects of burn therapy.
September 1953, The Ohio State medical journal,
F J Frey
Practical aspects of cytokine therapy.
May 1993, Stem cells (Dayton, Ohio),
F J Frey
Practical aspects of chewing therapy.
January 1956, Folia phoniatrica,
F J Frey
[Practical aspects of obstetrical therapy].
January 1957, La Rassegna di clinica, terapia e scienze affini,
F J Frey
Practical aspects of anthralin therapy.
October 1990, Cutis,
F J Frey
Practical aspects of burn therapy.
June 1962, The American surgeon,
Copied contents to your clipboard!